TABLE 3

Changes in miRNA associated with chemosensitivity to cisplatin

miRNACellsTargetsReferences
miR-7MCF-7MRP1Pogribny et al., 2010
miR-141ESCCYAP1Imanaka et al., 2011
miR-148aSCC, EACUnknownHummel et al., 2011
miR-181bA549BCL2Zhu et al., 2010
miR-181dUMSCC-1, SQ20BUnknownDai et al., 2011
miR-196A549UnknownTang et al., 2010
miR-200cTE8-RAktHamano et al., 2011
miR-345MCF-7MRP1Pogribny et al., 2010
miR-497A549BCL2Zhu et al., 2011b
miR-130aA2780CISM-CSFSorrentino et al., 2008
Let-7i2008, SKOV3, MCF7UnknownYang et al., 2008b
miR-214HIOSEPTEN/AktYang et al., 2008a
miR-372/373TGCTNEO1/LATS2Duale et al., 2007
miR-98SCC-4HMGA2Hebert et al., 2007
  • KB, human cervical epidermal carcinoma cells; ESCC, human esophageal squamous cell carcinoma; A549, human lung cancer cells; TEB-R, human esophageal squamous cell carcinoma, CP-r; UMSCC-1 & SQ20B, human head and neck squamous cell carcinoma; MCF7, human breast adenocarcinoma cells; SKOV3 & 2008, human ovarian cancer cells; HIOSE, human immortalized ovarian surface epithelial cells; TGCT, testicular germ cell tumor cells; SCC-4, human oral squamous cell carcinoma (SCC) cells.